TLR4 single nucleotide polymorphisms and thrombosis risk in patients with myeloproliferative disorders.
Speletas
M
M
Department of Immunology and Histocompatibility, School of Medicine, University Hospital of Thessaly, Larissa, 41110 Larissa, Greece. maspel@med.uth.gr
Liadaki
K
K
Kalala
F
F
Daiou
C
C
Katodritou
E
E
Mandala
E
E
Korantzis
I
I
Ritis
K
K
Zintzaras
E
E
Germenis
A E
AE
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001854:Bone Marrow Cells / Q000473:pathology; D004247:DNA / Q000235:genetics / Q000302:isolation & purification; D005260:Female; D005838:Genotype; D006801:Humans; D008297:Male; D008875:Middle Aged; D009196:Myeloproliferative Disorders / Q000150:complications / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide; D012307:Risk Factors; D013927:Thrombosis / Q000453:epidemiology* / Q000235:genetics*; D051197:Toll-Like Receptor 4 / Q000235:genetics*
C495345:TLR4 protein, human; D051197:Toll-Like Receptor 4; D004247:DNA